629
Views
1
CrossRef citations to date
0
Altmetric
Theory and Methods Special Issue on Precision Medicine and Individualized Policy Discovery, Part II

Discussion of Kallus (2020) and Mo et al. (2020)

ORCID Icon &
Pages 690-693 | Received 11 Sep 2020, Accepted 03 Oct 2020, Published online: 01 Apr 2021
 

Abstract

We discuss the results on improving the generalizability of individualized treatment rule following the work by Kallus and Mo et al. We note that the advocated weights in the work of Kallus are connected to the efficient score of the contrast function. We further propose a likelihood-ratio-based method (LR-ITR) to accommodate covariate shifts, and compare it to the CTE-DR-ITR method proposed by Mo et al. We provide the upper-bound on the risk function of the target population when both the covariate shift and the contrast function shift are present. Numerical studies show that LR-ITR can outperform CTE-DR-ITR when there is only covariate shift. Supplementary materials for this article are available online.

View responses to this article:
Rejoinder: New Objectives for Policy Learning
Rejoinder: New Objectives for Policy Learning

Supplementary Materials

Proof of Theorem 3.1 is provided in the supplementary materials.

Additional information

Funding

The authors gratefully acknowledge support by R01DK108073 awarded by the National Institutes of Health.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.